|
Premature Ejaculation | Shim Clinic, Singapore
|
|
Summary
Premature Ejaculation | Shim Clinic, Singapore: premature ejaculation (PE) treatment with medication like dapoxetine (Priligy®) clinic, Singapore. Definitions, references, and latest news.
Description
Priligy® (dapoxetine) is in stock at Shim Clinic, NOW! Table of Contents Premature ejaculation criteria stated in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, text revision (DSM-IV-TR) is as follows: - persistent and recurrent ejaculation with minimal sexual stimulation before, on, or shortly after penetration before the person wishes it;
- marked distress or interpersonal difficulty; and
- not exclusively due to direct effects.
1 Tool for Assessing Premature Ejaculation Score: ≤8 "no PE," 9 and 10 "probable PE," and ≥11 "PE." References Premature ejaculation treatment is frequently done with the prescription of premature ejaculation medication which are usually selective serotonin reuptake inhibitors (SSRIs) like Dapoxetine (Priligy®) Men's health issues: Priligy® (dapoxetine) is in stock at Shim Clinic, NOW!
References
Latest News
Apricus Biosciences Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation
Tue, 17 Jan 2012 15:03:00 +0100 | Medical News (via PRIMEZONE)
SAN DIEGO, Jan. 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that the Israeli Patent Office recently issued a Notice of Allowance to grant a patent for the Company's development of a topical cream utilizing vasoactive prostaglandin E to treat premature ejaculation ("PE"). When issued, the patent, entitled, "Compositions and Methods for the Treatment of Premature Ejaculation," will provide Israeli patent protection until March 2024. It is one in a series of issued patents and pending applications that Apricus Bio owns in the male sexual dysfunction field utilizing its proprietary NexACT(r) technology, which includes its Vitaros(r) product to treat erectile dysfunction ("ED"), among others in...
Does Current Scientific and Clinical Evidence Support the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature Ejaculation? A Systematic Review and Meta‐analysis
Mon, 16 Jan 2012 05:00:00 +0100 | The Journal of Sexual Medicine
Conclusion. There is inadequate, partial basic, and clinical evidence to support the use of PDE5 for the treatment of PE. Asimakopoulos AD, Miano R, Agrò EF, Vespasiani G, and Spera E. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta‐analysis. J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)
Complete foreskin removal in adult circumcision: Is it a new direction to definitive cure of premature ejaculation?
Wed, 04 Jan 2012 05:00:00 +0100 | Indian Journal of Urology
Neeraj Kumar GoyalIndian Journal of Urology 2011 27(4):562-563 (Source: Indian Journal of Urology)
Erectile Dysfunction and Premature Ejaculation in Men Who Have Sex with Men
Tue, 03 Jan 2012 05:00:00 +0100 | The Journal of Sexual Medicine
Conclusions. Risk factors for sexual problems in MSM are similar to what has been observed in quantitative studies of non‐MSM males. Urinary symptoms are associated with poorer sexual function in MSM. Shindel AW, Vittinghoff E, and Breyer BN. Erectile dysfunction and premature ejaculation in men who have sex with men. J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)
Men's Health: Sexual Dysfunction, Physical, and Psychological Health—Is There a Link?
Wed, 21 Dec 2011 05:00:00 +0100 | The Journal of Sexual Medicine
Conclusion. The association between men's sexual dysfunction and physical and psychological health is real and proven. Therefore, it should not be taken lightly but instead treated as a life‐threatening medical problem. Tan HM, Tong SF, and Ho CCK. Men's health: Sexual dysfunction, physical, and psychological health—Is there a link? J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)
Are Urology Residents Ready to Treat Premature Ejaculation After Their Training?
Wed, 21 Dec 2011 05:00:00 +0100 | The Journal of Sexual Medicine
Conclusions. The majority of URs follow the established guidelines for diagnosis of PE, but not for treatment. The URs have an insufficient medical education in sexual medicine. Luján S, García‐Fadrique G, Morales G, Morera J, Broseta E, and Jiménez‐Cruz JF. Are urology residents ready to treat premature ejaculation after their training? J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)
Silodosin and its potential for treating premature ejaculation: A preliminary report
Tue, 20 Dec 2011 05:00:00 +0100 | International Journal of Urology
AbstractPremature ejaculation is a common sexual problem, as is erectile dysfunction. We evaluated silodosin, a highly selective α1A‐adrenoceptor antagonist, as a new treatment option for premature ejaculation. α1‐Adrenoceptor antagonists are widely used for lower urinary tract symptoms, and clinical studies on silodosin have shown excellent clinical efficacy for lower urinary tract symptoms. However, compared with other α1‐adrenoceptor antagonists, silodosin appeared to suppress ejaculation in a relatively higher percent of trial participants. This suppression of ejaculation by silodosin suggested its potential for treating premature ejaculation. Consequently, we evaluated the feasibility of off‐label silodosin as a new treatment option for premature ejaculation. Eight patients...
Escitalopram for Premature Ejaculation Affects SemenEscitalopram for Premature Ejaculation Affects Semen
Fri, 09 Dec 2011 04:00:00 +0100 | Medscape Today Headlines
Previous studies have shown that escitalopram can be beneficial in the treatment of premature ejaculation, but does it inhibit fertility? International Journal of Impotence Research (Source: Medscape Today Headlines)
The Global Online Sexuality Survey (GOSS): Female Sexual Dysfunction among Internet Users in the Reproductive Age Group in the Middle East
Tue, 06 Dec 2011 05:00:00 +0100 | The Journal of Sexual Medicine
Conclusion. Female sexual function in the reproductive age appears to be adversely affected by psychological factors and shortcomings in male sexual function more than anything. These findings point to the possibility that many cases of FSD can be managed with the focus on male partner's ailments and attitudes that are relatively easier to manage. Shae er O, Shaeer K, and Shaeer E. The Global Online Sexuality Survey (GOSS): Female sexual dysfunction among Internet users in the reproductive age group in the Middle East. J Sex Med **;**:**–**. (Source: The Journal of Sexual Medicine)
|